Sara Payan

Public Education Officer, The Apothecarium

Sara Payan is a nationally recognized cannabis educator, speaker, public policy advocate, writer and consultant. She is the Public Education Officer for the Apothecarium in San Francisco and vice-chair of the San Francisco Cannabis State Legalization Task Force. Sara has had the honor of speaking and lecturing at such events as Patients Out of Time, Women Grow and The Women's Visionary Congress and the Arkansas Cannabis Industry Association. With over 10,000 hours of hands-on experiential medical cannabis patient research, Sara has consulted with many large healthcare organizations such as Kaiser and UCSF, to help them better understand the role cannabis can play in their patients’ lives. She has lead large-scale industry training and lectures nationwide, including continuing education credit classes at accredited schools for healthcare practitioners through her private practice.

Sara created and taught the first cannabis education workshop series for City College of San Francisco’s Continuing Education program. The desire to bear witness and help others suffering through illness is what moved her to become an educator, advocate and activist for medical cannabis patients and is what drives her to lead the movement in normalizing cannabis use for health. Her experience as a stage III colon cancer survivor and her civil rights background fueled her passion for about creating safe access to cannabis through education and also inspired her to create a compassionate consulting training program for those in the medical cannabis industry and beyond. Her work has been highlighted in Dope Magazine, Cannabis Now, High Times and Ladybud. Sara is a graduate of the California Institute of Integral Studies. She is also a writer for Cannabis Now.

Matthew Greene

New York, NY, USA
CEO & Founder, Edible Science, LLC

Matt Greene has spent his entire career in the marketing, advertising and AdTech industry. His fascination with technology began in 1987 while working with his client Steve Jobs in developing the launch strategies for NeXT Computers. Starting in 1998, Matt pioneered online advertising and supporting technologies for the digital ad agency he founded, Blue Ribbon Digital, where his team drove innovation across all aspects of digital media - from Search to Mobile and Video, his agency measurably generated over $2BB in revenues for their Fortune 100 clients. In this capacity, Matt has spoken at leading conferences such as AdTech, iMedia Summits and the Googleplex in Mountain View, CA. Starting in 2015, Matt re-focused his energies on the burgeoning cannabis industry knowing that the need for innovation in technologies to support the industry would be mandatory. With his his new company, Edible Sciences, he and his team on concentrating their energies in solving the #1 problem facing the edibles sector: Dosing Accuracy. He will be speaking at Binghampton University's TIER Talks in SEPT '17 on technology innovations occurring in the cannabis ancillary space.

Brett Finkelstein

Boca Raton, FL
Managing Director, Phyto Partners LP

Brett is an experienced executive, venture capital and private equity investor and advisor. He has partnered with, worked with and developed key relationships with numerous premier private equity, investment banks, and venture capital companies. As one of the founders of Phyto Partners LP, Brett’s fundamental ambition for the company’s stakeholders is to creatively apply his unique resources of extensive operating skills, certainty to close, access to capital, extensive network of resources and relentless pursuit of excellence to facilitate a more super-charged evolution for enterprises we fund, launch, and maintain activist roles in. For the powerhouse companies we invest in, advise, and or buy we will be providing more investment value and a comfort level for our financial capital partners, as well as our portfolio companies that join us. Phyto Partners LP was profiled in Forbes as one of the leaders in the cannabis industry. Phyto has invested in half of what CB insights profiled as the trailblazers of 2017.